Belgium· BE-AMP-SAM122857-00
Prioderm 0.5 %
A malathion product containing malathion, registered in Belgium by Viatris Healthcare. The same ATC class is registered in 5 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Malathion is registered in 5 of 19 countries.
Countries holding a registration under ATC P03AX03 (malathion), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 3 of them publish a price we can compare per daily dose
Malathion · ATC P03AX03
5 / 19 countries
- Belgiumprice
- Finlandprice
- Ireland
- United Kingdom
- United Statesprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Malathion
- Manufacturer
- Viatris Healthcare
- Country
- Belgium (BE)
- ATC code
- P03AX03
- ATC class
- Malathion
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 1
- be_apb0815852
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Malathion in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomDerbac-M 0.5% liquidWaymade Healthcare Plc
- United StatesMalathionSun Pharmaceutical Industries, Inc.
- FinlandPriodermMundipharma Oy
- IrelandDerbac M Liquid 0.5% w/w cutaneous emulsionLanesHealth (Ireland) Limited
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- United Kingdom (Northern Ireland) · Derbac M, Prioderm
- Ireland · Derbac M Liquid
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cb6ede0e-fef2-44d0-b09f-669273b6d049 GET /v1/drugs/cb6ede0e-fef2-44d0-b09f-669273b6d049?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Cutaneous solution",
"source": "afmps",
"status": "REVOKED",
"name_en": "Prioderm 0.5 %",
"name_fr": "Prioderm 0.5 %",
"name_nl": "Prioderm 0.5 %",
"amp_code": "SAM122857-00",
"strengths": [
"5.0000",
"5.0000",
"5.0000",
"10.0000"
],
"pack_count": 1,
"substances": [
"Malathion",
"Limonene (DL)"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Malathion",
"authorisation_numbers": [
"BE122857"
]
}See everything about malathion.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.